VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan. 13, 2017) - Valens GroWorks Corp.
(CSE:VGW)(CSE:VGW.CN)(the "Company") is pleased to announce the completion, by the Regional
Inspectorate of the Office of Controlled Substances of Health Canada, of their final inspection of wholly-owned subsidiary Valens
Agritech's ("VAL") 17,000 square foot R&D facility located in Kelowna, British Columbia.
The inspection is the final stage required to achieve licensing under our application for a Controlled Drugs and Substances
Dealer's Licence to enable the cultivation and processing of marijuana (such as creating extracts or derivatives) for the purpose
of research, for processing manufacturing derivatives, and for transporting product to other locations (including related
packaging, possession, sale, delivery and research activities).
Final pre-inspection preparation included the installation of significant enhanced physical security measures, the
establishment of specified record keeping procedures, and the engagement of a Qualified Person In Charge (QPIC).
The Company is therefore pleased to announce Dr. Yasantha Athukorala, Ph.D. as the QPIC for VAL, as well as VAL's Chief
Scientific Officer. Dr. Athukorala is an accomplished scientist with outstanding research and leadership skills and more than 7
years of experience investigating bioactive compounds from agricultural bio-resources. With a unique background of Biotechnology,
Chemistry and Bio-resource Technology knowledge, Dr. Athukorala brings a demonstrated record of project and publication success,
credited with discovering naturally-occurring bioactive compounds using enzymatic digestion, bioassay-guided extraction and
fractionation procedures with potential commercial applications in food, health and bio-resource utilization industries.
Dave Gervais, President of VAL., stated, "We warmly welcome Dr. Athukorala to the Valens team as we gear up to commence
operations pending receipt of Health Canada's Dealer's Licence approval. Yasantha is a dedicated and creative scientist with
superb transdisciplinary communication, relationship-building and team leadership attributes, and will be supported by a fully
qualified alternate QPIC as we ramp up operations".
About Valens GroWorks Corp.
The Company recently completed the acquisition of Valens Agritech Ltd. ("VAL"). VAL is a biotechnology
company based in the Okanagan Valley of British Columbia, focused on cannabis cultivation and research, with assets and
improvements that include a state-of-the-art 17,000 square foot R&D facility located in Kelowna, British Columbia.
Post-licensing, Valens anticipates participation in clinical trial programs researching the efficacy of medical cannabis for
certain indications, and will also be seeking to capture a broad spectrum of medical marijuana users, as well as recreational
users once legalized, in pursuit of its farm to pharma objectives.
On behalf of the Board of Directors,
VALENS GROWORKS CORP.
Robert van Santen, Chief Executive Officer
Cautionary statements
This press release contains forward-looking information based on current expectations. Statements about the
Company's expectations are all forward-looking information. These statements should not be read as guarantees of future
performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual
results, performance or achievements to be materially different from those implied by such statements. Valens Groworks assumes no
responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law.
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities
Exchange) accepts responsibility for the adequacy or accuracy of this release. We seek safe harbor.